In the News
Six drugs that could change the world
The strength of the state’s world-class drug developers is usually measured in terms of jobs and economics, rather than the effect on human health in coming [...]
Startup Finds Hope in Second Look at “Failed” Alzheimer’s Drugs
Alzheon will first take a closer look at a drug designed to target the brain-damaging amyloid plaques that are the hallmarks of Alzheimer’s. In the hands [...]
Alzheimer’s team tackles a daunting R&D field with a new game plan
The drug is tramiprosate, which flunked a big study back in 2009. It's been rebuilt, so to speak, so it can be delivered through the gut [...]
Alzheon Emerges From Stealth, Hunts for Alzheimer’s Castoffs
Clinical trial flops have become the norm for Alzheimer’s disease treatments, despite the billions put into research for the memory-robbing disorder. But a new Lexington, MA-based [...]